Resultados da busca - Viskochil, David
- Mostrando 1 - 20 resultados de 62
- Ir para a próxima página
-
1
-
2
-
3
-
4
-
5
C→U Editing of Neurofibromatosis 1 mRNA Occurs in Tumors That Express Both the Type II Transcript and apobec-1, the Catalytic Subunit of the Apolipoprotein B mRNA–Editing Enzyme... por Mukhopadhyay, Debnath, Anant, Shrikant, Lee, Robert M., Kennedy, Susan, Viskochil, David, Davidson, Nicholas O.
Publicado em 2002Texto -
6
Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study por Seidlin, Mindell, Holzman, Robert, Knight, Pamela, Korf, Bruce, Rangel Miller, Vanessa, Viskochil, David, Bakker, Annette
Publicado em 2017Texto -
7
Lost in Translation: Ambiguity in Nerve Sheath Tumor Nomenclature and Its Resultant Treatment Effect por Bernthal, Nicholas M., Jones, Kevin B., Monument, Michael J., Liu, Ting, Viskochil, David, Randall, R. Lor
Publicado em 2013Texto -
8
NF1 Exon 22 Analysis of Individuals with the Clinical Diagnosis of Neurofibromatosis Type 1 por Muram-Zborovski, Talia M., Vaughn, Cecily P., Viskochil, David H., Hanson, Heather, Mao, Rong, Stevenson, David A.
Publicado em 2010Texto -
9
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies por Kim, AeRang, Stewart, Douglas R., Reilly, Karlyne M., Viskochil, David, Miettinen, Markku M., Widemann, Brigitte C.
Publicado em 2017Texto -
10
-
11
-
12
Lower Extremity Strength and Hopping and Jumping Ground Reaction forces in Children with Neurofibromatosis Type 1 por Johnson, Barbara, MacWilliams, Bruce, Carey, John C., Viskochil, David H., D’Astous, Jacques L., Stevenson, David A.
Publicado em 2011Texto -
13
Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1 por Stevenson, David A., Moyer-Mileur, Laurie J., Murray, Mary, Slater, Hillarie, Sheng, Xiaoming, Carey, John C., Dube, Bukhosi, Viskochil, David H.
Publicado em 2007Texto -
14
Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal models por DeClue, Jeffrey E., Heffelfinger, Sue, Benvenuto, Giovanna, Ling, Bo, Li, Shaowei, Rui, Wen, Vass, William C., Viskochil, David, Ratner, Nancy
Publicado em 2000Texto -
15
Low Bone Mineral Content and Challenges in Interpretation of Dual-Energy X-Ray Absorptiometry in Children With Mucopolysaccharidosis Types I, II, and VI por Polgreen, Lynda E., Thomas, William, Fung, Ellen, Viskochil, David, Stevenson, David A., Steinberger, Julia, Orchard, Paul, Whitley, Chester B., Ensrud, Kristine E.
Publicado em 2013Texto -
16
Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results program, 2000–2014 por Peckham-Gregory, Erin C., Montenegro, Roberto E., Stevenson, David A., Viskochil, David H., Scheurer, Michael E., Lupo, Philip J., Schiffman, Joshua D.
Publicado em 2018Texto -
17
Evaluation of racial disparities in pediatric optic pathway glioma incidence: results from the Surveillance, Epidemiology, and End Results program, 2000–2014 por Peckham-Gregory, Erin C., Montenegro, Roberto E., Stevenson, David A., Viskochil, David H., Scheurer, Michael E., Lupo, Philip J., Schiffman, Joshua D.
Publicado em 2018Texto -
18
-
19
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities por Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb
Publicado em 2020Texto -
20
Biomarkers of Bone Remodeling in Children with Mucopolysaccharidosis Types I, II, and VI por Stevenson, David A., Rudser, Kyle, Kunin-Batson, Alicia, Fung, Ellen B., Viskochil, David, Shapiro, Elsa, Orchard, Paul J., Whitley, Chester B., Polgreen, Lynda E.
Publicado em 2014Texto